- Home
- SGLY vs BFRG Comparison
SGLY vs BFRG Comparison
Compare SGLY & BFRG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | SGLY | BFRG |
|---|---|---|
| Founded | 2001 | 2017 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | | Retail: Computer Software & Peripheral Equipment |
| Sector | | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 8.5M | 10.7M |
| IPO Year | 2008 | 2022 |
Fundamental Metrics
Financial Performance| Metric | SGLY | BFRG |
|---|---|---|
| Price | $1.14 | $0.47 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | ★ 1.1M | 88.6K |
| Earning Date | 05-15-2026 | 05-12-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 48.29 | 25.88 |
| EPS | N/A | ★ N/A |
| Revenue | ★ $1,813,193.00 | $116,670.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | ★ 79.49 |
| 52 Week Low | $0.18 | $0.43 |
| 52 Week High | $8.65 | $2.04 |
Technical Indicators
Market Signals| Indicator | SGLY | BFRG |
|---|---|---|
| Relative Strength Index (RSI) | 36.32 | 28.09 |
| Support Level | $0.36 | $0.43 |
| Resistance Level | $8.65 | $0.69 |
| Average True Range (ATR) | 0.22 | 0.03 |
| MACD | -0.05 | -0.01 |
| Stochastic Oscillator | 0.00 | 4.89 |
Price Performance
Historical ComparisonAbout SGLY Singularity Future Technology Ltd.
Singularity Future Technology Ltd is an investment holding company. The company's operating segment includes Freight Logistics Services and Sale of Crypto-mining Machines. It generates maximum revenue from the Freight Logistics Services segment. Geographically, it derives a majority of its revenue from China.
About BFRG Bullfrog AI Holdings Inc.
Bullfrog AI Holdings Inc is a clinical-phase Biotechnology company using machine learning to advance medicine and improve human health. It uses artificial intelligence and machine learning to advance medicines for both internal and external projects. The Company is focused specifically on advance artificial intelligence and machine learning (AI/ML)- driven analysis of complex datasets in medicine and healthcare. The Company's objective is to use its AI/ML platform to provide a precision-medicine approach to drug-asset enablement through external partnerships and selective internal development.